throbber
Paper No. ____
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`
`MYLAN TECHNOLOGIES, INC.
`Petitioner
`v.
`
`NOVEN PHARMACEUTICALS, INC.
`Patent Owner.
`
`_______________
`
`Case No. IPR2018-00174
`U.S. Patent No. 9,730,900
`____________________________________________________________
`
`
`NOVEN PHARMACEUTICALS, INC.’S
`MANDATORY NOTICES UNDER 37 C.F.R. § 42.8
`
`
`
`
`
`4823-5309-6537.1
`
`
`
`

`

`U.S. Patent No. 9,730,900
`IPR2018-00174
`
`Pursuant to 37 C.F.R. § 42.8, Noven Pharmaceuticals, Inc. (“Noven”)
`
`provides this Mandatory Notice within 21 days of service of the Petition (Paper 2)
`
`on December 4, 2017.
`
`I.
`
`Real Party-in-Interest Pursuant to 37 C.F.R. § 42.8 (b)(1):
`
`Noven is the sole owner of U.S. Patent No. 9,730,900 (the “’900 patent”).
`
`Noven Pharmaceuticals, Inc., a wholly owned subsidiary of Hisamitsu
`
`Pharmaceutical Co., Inc., and Hisamitsu Pharmaceutical Co., Inc. are the real
`
`parties-in-interest with respect to the Patent Owner in IPR2018-00174.
`
`II. Related Matters Pursuant to 37 C.F.R. § 42.8 (b)(2):
`
`Noven is aware of the following judicial or administrative matters that
`
`would affect, or be affected by, a decision in the instant proceeding:
`
`The ’900 patent is being asserted in the following patent infringement
`
`lawsuits currently pending in the United States District Court for the District of
`
`Delaware: (1) Noven Pharmaceuticals, Inc. v. Alvogen Pine Brook LLC et al., C.A.
`
`No. 1-17-cv-01429-LPS (D. Del.); and (2) Noven Pharmaceuticals, Inc. v. Mylan
`
`Technologies Inc. et al., C.A. No. 1-17-cv-01777 (D. Del.).
`
`U.S. Patent No. 9,724,310 (“the ’310 patent”) claims benefit of the ’900
`
`patent. The ’310 patent is being asserted in each of the above-listed lawsuits. The
`
`’310 patent also is the subject of a petition for Inter Partes Review, IPR2018-
`
`
`
`1
`
`

`

`U.S. Patent No. 9,730,900
`IPR2018-00174
`
`00173, filed on December 4, 2017.
`
`The ’900 patent is a continuation of U.S. Patent Application No. 12/216,811,
`
`now U.S. Patent No. 8,231,906 (the ’906 patent”). The ’906 patent was asserted in
`
`the following patent infringement lawsuits currently pending in the United States
`
`District Court for the District of Delaware: (1) Noven Pharmaceuticals, Inc. v.
`
`Actavis Laboratories UT Inc., C.A. No. 1-15-cv-00249-LPS (D. Del.); and
`
`(2) Noven Pharmaceuticals, Inc. v. Actavis Laboratories UT Inc., C.A. No. 1-16-
`
`cv-00465 (D. Del.). The ’906 patent also was the subject of the following patent
`
`infringement lawsuits which have terminated: (1) Alvogen Pine Brook LLC v.
`
`Noven Pharmaceuticals, Inc., C.A. No. 1-16-cv-00395-LPS (D. Del.); (2) Noven
`
`Pharmaceuticals, Inc. v. Mylan Technologies Inc. et al., C.A. No. 1-15-cv-00069
`
`(N.D.W. Va.); and (3) Noven Pharmaceuticals, Inc. v. Mylan Technologies Inc. et
`
`al., C.A. No. 1-15-cv-00328 (D. Del.).
`
`The following pending continuing patent application claims the benefit of
`
`the ’906, ’310, and ’900 patents: U.S. Patent Application No. 14/738,255.
`
`III. Lead and Back-Up Counsel Pursuant to 37 C.F.R. §§ 42.8(b)(3):
`
`Noven designates the following Lead and Back-up Counsel. Since the
`
`designated counsel is already counsel of record in the subject patent, a power of
`
`attorney is not being concurrently submitted pursuant to 37 C.F.R. § 42.10(b).
`
`
`
`2
`
`

`

`U.S. Patent No. 9,730,900
`IPR2018-00174
`
`Back-up Counsel
`Jason N. Mock
`Reg. No. 69,186
`
`Foley & Lardner LLP
`3000 K Street, N.W. , Suite 600
`Washington, D.C. 20007-5109
`JMock@foley.com
`Tel: 202-295-4775
`Fax: 202-672-5399
`
`Lead Counsel
`Courtenay C. Brinckerhoff
`Reg. No. 37,288
`
`Foley & Lardner LLP
`3000 K Street, N.W. , Suite 600
`Washington, D.C. 20007-5109
`CBrinckerhoff@foley.com
`Tel: 202-295-4094
`Fax: 202-672-5399
`
`
`
`IV. Service Information Pursuant to 37 C.F.R. §§ 42.8(b)(4):
`
`Pursuant to the requirements of 37 C.F.R. § 42.8(b)(4), Noven may be
`
`served by postal mailing or hand-delivery as follows:
`
`Courtenay C. Brinckerhoff
`Foley & Lardner LLP
`3000 K Street, N.W. , Suite 600
`Washington, D.C. 20007-5109
`
`Noven also consents to service by electronic mail at:
`
`CBrinckerhoff@foley.com
`
`JMock@foley.com and
`
`FIRM-Noven-MylanIPRs@foley.com.
`
`
`
`3
`
`
`
`
`
`
`
`

`

`Any questions concerning this paper may be directed to lead counsel.
`
`U.S. Patent No. 9,730,900
`IPR2018-00174
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: December 21, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Courtenay C. Brinckerhoff /
`Courtenay C. Brinckerhoff
`Registration No. 37,288
`
`Jason N. Mock
`Registration No. 69,186
`
`Counsel for Patent Owner
`Foley & Lardner LLP
`
`4
`
`

`

`U.S. Patent No. 9,730,900
`IPR2018-00174
`
`CERTIFCATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Noven
`
`Pharmaceutical, Inc.’s Mandatory Notices Under 37 C.F.R. § 42.8 was served
`
`on December 21, 2017, by email directed to the attorneys of record for the
`
`Petitioner at the following addresses:
`
`sparmelee@wsgr.com
`mrosato@swgr.com
`jmills@wsgr.com
`
`By: /Courtenay C. Brinckerhoff /
`Courtenay C. Brinckerhoff
`Registration No. 37,288
`
`Jason N. Mock
`Registration No. 69,186
`
`Counsel for Patent Owner
`Foley & Lardner LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket